We are dedicated to serving patients' needs and improving public health in China. Our mission is to help Chinese patients gain earlier access to more affordable, innovative medicines through partnerships, best-in-class research and development, and the disruptive application of digital and data insight.
WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced today a strategic collaboration with Brii Biosciences……
Brii Biosciences, a company committed to serving patients’ needs and improving public health in China, today announced several research collaborations that significantly advance its efforts to develop innovative medicines to meet the unique needs of patients in China.
